- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4 Registration of securities issued in business combination transactions
- 3.2 Certificate of Formation of Accessmed Holdings, LLC
- 3.2 Limited Liability Company Agreement of Accessmed Holdings, LLC
- 3.3 Articles of Organization of Accessmed, LLC
- 3.3 Limited Liability Company Agreement of Accessmed, LLC
- 3.4 Certificate of Formation of Aor Holding Company of Indiana, LLC
- 3.4 Limited Liability Company Agreement of Aor Holding Company of Indiana, LLC
- 3.5 Certificate of Formation of Aor Management Company of Arizona, LLC
- 3.5 Limited Liability Company Agreement of Aor Management Company of Arizona, LLC
- 3.6 Certificate of Formation of Aor Management Company of Indiana, LLC
- 3.6 Limited Liability Company Agreement of Aor Management Company of Indiana, LLC
- 3.7 Certificate of Formation of Aor Management Company of Missouri, LLC
- 3.7 Limited Liability Company Agreement of Aor Management Company of Missouri, LLC
- 3.8 Certificate of Formation of Aor Management Company of Oklahoma, LLC
- 3.8 Limited Liability Company Agreement of Aor Management Company of Oklahoma, LLC
- 3.9 Certificate of Formation of Aor Management Company of Pennsylvania, LLC
- 3.9 Limited Liability Company Agreement of Aor Management Company of Pennsylvania
- 3.10 Certificate of Formation of Aor Management Company of Virginia, LLC
- 3.10 Limited Liability Company Agreement of Aor Management Company of Virginia, LLC
- 3.12 Certificate of Formation of Aor of Texas Management, LLC
- 3.12 Limited Liability Company Agreement of Aor of Texas Management, LLC
- 3.13 Certificate of Formation of Aor Real Estate, LLC
- 3.13 Limited Liability Company Agreement of Aor Real Estate, LLC
- 3.14 Certificate of Formation of Aor Synthetic Real Estate, LLC
- 3.14 Limited Liability Company Agreement of Aor Synthetic Real Estate, LLC
- 3.15 Certificate of Incorporation of Aort Holding Company, Inc.
- 3.15 Bylaws of Aort Holding Company, Inc.
- 3.17 Certificate of Formation of Innovent Oncology, LLC
- 3.17 Limited Liability Company Agreement of Innovent Oncology, LLC
- 3.22 Certificate of Limited Partnership of Oncology RX Care Advantage, LP
- 3.22 Agreement of Limited Partnership of Oncology RX Care Advantage, LP
- 3.23 Certificate of Limited Partnership of Incorporation of Oncology Today, LP
- 3.23 Agreement of Limited Partnership of Oncology Today, LP
- 3.24 Certificate of Formation of Physician Reliance, LLC
- 3.24 Limited Liability Company Agreement of Physician Reliance, LLC
- 3.25 Certificate of Formation of Physician Reliance Network, LLC
- 3.25 Limited Liability Company Agreement of Physician Reliance Network, LLC
- 3.26 Certificate of Formation of RMCC Cancer Center, LLC
- 3.26 Limited Liability Company Agreement of RMCC Cancer Center, LLC
- 3.31 Certificate of Formation of Unity Oncology, LLC
- 3.31 Limited Liability Company Agreement of Unity Oncology, LLC
- 3.32 Certificate of Formation of Us Oncology Clinical Development, LLC
- 3.32 Limited Liability Company Agreement of Us Oncology Clinical Development, LLC
- 3.34 Certificate of Limited Partnership of Us Oncology Integrated Solutions, LP
- 3.34 Agreement of Limited Partnership of Us Oncology Integrated Solutions, LP
- 3.35 Limited Liability Company Agreement of Us Oncology Pharmaceutical Services, LLC
- 3.36 Certificate of Formation of Us Oncology Reimbursement Solutions, LLC
- 3.36 Amended and Restated Limited Liability Company Agreement
- 3.37 Certificate of Formation of Us Oncology Research, LLC
- 3.37 Limited Liability Company Agreement of Us Oncology Research, LLC
- 3.38 Certificate of Limited Partnership of Us Oncology Specialty, LP
- 3.38 Agreement of Limited Partnership of Us Oncology Specialty, LP
- 4.17 Collateral Agreement, Dated As of June 18, 2009
- 4.18 Lien Subordination and Intercreditor Agreement Dated June 18, 2009
- 5.1 Opinion of Ropes & Gray LLP
- 5.2 Opinion of Hackman Hulett & Cracraft, LLP
- 5.3 Opinion of Foulston Siefkin LLP
- 5.4 Opinion of Andrews Kurth LLP
- 12.1 Statements Re: Computation of Ratios
- 21.1 Subsidiaries of the Registrant
- 23.2 Consent of Pricewaterhousecoopers LLP
- 25.1 Statement on Form T-1 As to the Eligibility of the Trustee
- 99.1 Form of Letter of Transmittal
- 99.2 Form of Notice of Guaranteed Delivery
- 7 Dec 09 Registration of securities issued in business combination transactions (amended)
- 26 Oct 09 Registration of securities issued in business combination transactions (amended)
- 15 Oct 09 Registration of securities issued in business combination transactions
- 16 Mar 05 Registration of securities issued in business combination transactions (amended)
- 14 Mar 05 Registration of securities issued in business combination transactions (amended)
- 17 Dec 04 Registration of securities issued in business combination transactions
Exhibit 3.34(a)
| State of Delaware | ||||
| Secretary of State | ||||
| Division of Corporations | ||||
| Delivered 04:58 PM 03/24/2006 | ||||
| FILED 04:52 PM 03/24/2006 | ||||
| SRV 060284699 - 4131753 FILE |
CERTIFICATE OF LIMITED PARTNERSHIP
OF
Oncology Market Focus, LP
The undersigned, desiring to form a limited partnership pursuant to the Delaware Revised Uniform Limited Partnership Act, 6 Delaware Code, Chapter 17, do hereby certify as follows:
I. The name of the limited partnership is Oncology Market Focus, LP.
II. The address of the Partnership’s registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, Wilmington, New Castle County, Delaware, 19801. The name of the Partnership’s registered agent for service of process in the State of Delaware at such address is The Corporation Trust Company.
III. The name and mailing address of each general partner is as follows:
Name | Address | Percent Interest | ||
| US Oncology Corporate, Inc. | 16825 Northchase Drive, Suite 1300 | 1 % General Partner | ||
| Houston, TX 77060 | ||||
| AORT Holding Company, Inc. | 16825 Northchase Drive, Suite 1300 | 99% Limited Partner | ||
| Houston, TX 77060 | ||||
IN WITNESS WHEREOF, the undersigned have executed this Certificate of Limited Partnership on this 23rd day of March, 2006.
| By: |
| |
| Phillip H. Watts, Vice President | ||
| US Oncology Corporate, Inc., General Partner | ||
| By: |
| |
| Phillip H. Watts, Vice President | ||
| AORT Holding Company, Inc., Limited Partner | ||
DE076 - 01/14/2005 C T System Online
| State of Delaware | ||||
| Secretary of State | ||||
| Division of Corporations | ||||
| Delivered 04:06 PM 10/02/2008 | ||||
| FILED 04:05 PM 10/02/2008 | ||||
| SRV 081008354 - 4131753 FILE |
STATE OF DELAWARE
AMENDMENT TO THE CERTIFICATE OF
LIMITED PARTNERSHIP
The undersigned, desiring to amend the Certificate of Limited Partnership pursuant to the provisions of Section 17-202 of the Revised Uniform Limited Partnership Act of the State of Delaware, does hereby certify as follows:
FIRST: The name of the Limited Partnership is | Oncology Market Focus, LP |
SECOND: Article I of the Certificate of Limited Partnership shall be amended as follows:
The name of the limited partnership is US Oncology Integrated Solutions, LP
|
IN WITNESS WHEREOF, the undersigned executed this Amendment to the Certificate of Limited Partnership on this 2nd day of October , A.D. 2008 .
By: |
| |
| Phillip H. Watts, Vice President | ||
| US Oncology Corporate, Inc., General Partner(s) | ||
Name: | Phillip H. Watts | |
| Print or Type | ||
DE077 - 09/05/2007 C T System Online